CARVAC

Pharmaceuticals for humans, in particular for the prevention and treatment of cancer, infectious diseases, autoimmune disorders and other immunological diseases, in particular by way of nucleic acids, self-amplifying nucleic acids, viruses, viral like particles, peptides and proteins; Nucleic acid sequences for medical purposes in humans, namely, for purposes of encoding for receptor proteins for the stimulation and proliferation of cells of the immune systems

Medical and scientific research for humans, in particular in the fields of prevention and treatment of immunological diseases, cancer treatment, prevention of cancer, treatment of infectious diseases, and prevention of infectious diseases; providing human scientific research information, consultancy, and advisory services, in particular in the fields of prevention and treatment of immunological diseases, cancer treatment, prevention of cancer, treatment of infectious diseases, and prevention of infectious diseases

Medical services for humans, in particular providing therapy and vaccination approaches for treating and preventing cancer, infectious diseases and immunological diseases; medical and pharmaceutical consultation; medical human diagnostic testing, monitoring and reporting services; providing human medical information, consultancy, and advisory services, in particular in the fields of treatment and prevention of immunological diseases, cancer treatment, prevention of cancer, treatment of infectious diseases, and prevention of infectious diseases